Key Insights

Highlights

Success Rate

100% trial completion (above average)

Treatment Research

2 treatments under study, led by Plateletendothelial Proteomics

Research Leaders

7 sponsors active, led by The Rotunda Hospital

Related Conditions

Often studied with 9 related conditions

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 2 trials

Success Rate

100.0%

+13.4% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed with results

Key Signals

100% success

Data Visualizations

Phase Distribution

Trial Status

Unknown1
Completed1

Trial Success Rate

100.0%

Benchmark: 86.6%

Based on 1 completed trials

Clinical Trials (2)

Showing 2 of 2 trials
NCT05530330Completed

Markers of Platelet Activation foR Identification of Late Onset Sepsis in Preterm Infants

NCT05763680Unknown

Molecular Culture for the Diagnosis of Neonatal Sepsis

Showing all 2 trials

Research Network

Common Treatments

  • Plateletendothelial Proteomics1
  • Molecular Culture1

Active Sponsors

  • The Rotunda Hospital1
  • Wellcome Trust1
  • Jip Groen1
  • Health Research Board, Ireland1
  • University College Dublin1

Top Investigators

Related Conditions

  • Microbial Disease1
  • Necrotising Enterocolitis1
  • Neonatal Infection1
  • Clinical Sepsis1
  • Lateonset Neonatal Sepsis1

Activity Timeline